课题基金 / 基金详情

Modeling Duchenne muscular dystrophy using patient-derived iPS cells

Modeling Duchenne muscular dystrophy using patient-derived iPS cells
使用患者来源的 iPS 细胞模拟杜氏肌营养不良症
批准号:
24790383
负责人:
SAKURAI Hidetoshi
金额:
$2.91万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2012
资助国家:
日本
项目状态:
已结题
起止时间:
2012-04-01 至 2014-03-31

项目摘要

项目成果

SAKURAI Hidetoshi的其他基金

相似基金

相关文献

中文摘要
翻译
在这项研究中,我们使用患者来源的iPS细胞证明了Duchenne肌营养不良症(DMD)的早期发病机制。从DMD-iPSCs分化而来的DMD-肌肉表现出与对照IPSC来源的肌肉相似的基因表达谱和相似的成熟度,并且没有观察到DMD-肌肉的分化延迟。当DMD肌肉受到电刺激时,DMD肌肉的细胞内钙内流高于对照肌肉。离子霉素引起的钙超载对DMD肌的细胞损伤较对照肌大。由于这些表型可以通过外显子跳跃技术恢复dystrophin的表达而得到改善,我们得出结论,过量的钙内流是由dystrophin缺失引起的DMD早期发病的触发因素。根据我们的研究结果,我们将通过分析Dystrophin缺失引起的机制来开发针对过度钙内流的新药。
英文摘要
In this study, we demonstrated the early pathogenesis of Duchenne muscular dystrophy (DMD) using patient-derived iPS cells. DMD-muscles differentiated from DMD-iPSCs exhibited similar gene expression profile and similar maturity as control iPSC-derived muscles, and no differentiation delay was observed in DMD-muscles. When DMD-muscles were exposed to electric stimulation, higher intracellular Ca2+ influx was observed in DMD-muscles than control-muscles. Larger cell damage was observed in DMD-muscles than control-muscles through overloading Ca2+ by ionomycin. Since these phenotype could be ameliorated by restored dystrophin expression by exon skip technics, we conclude that excessive Ca2+ influx is the trigger for the early pathogenesis of DMD caused by absence of dystrophin. According to our findings, we are going to develop new drugs targeting excessive Ca2+ influx by analyzing the mechanism which is caused by absence of dystrophin.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
デュシェンヌ型筋ジストロフィー患者由来iPS細胞を用いての病態再現
使用源自杜氏肌营养不良症患者的 iPS 细胞再现病理状况
DOI: --
发表时间:
期刊:
影响因子: --
作者: [庄子栄美, 櫻井英俊, 中畑龍俊, 田中章仁, ウォルツェン クヌート, 藤井宣晴, 平家敏男, 真鍋康子, 瀬原-藤沢淳子]
通讯作者: 瀬原-藤沢淳子
Myotonic dystrophy type 1 patient-derived iPSCs for the investigation of CTG repeat instability
  • 批准号:
    26430053
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.33万
  • 财政年份:
    2014
  • 负责人:
    SAKURAI Hidetoshi
  • 依托单位:
Cell therapy for Muscular Dystrophy using myogenic progenitor cells derived from human iPS cells
  • 批准号:
    22790284
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
  • 资助金额:
    $2.58万
  • 财政年份:
    2010
  • 负责人:
    SAKURAI Hidetoshi
  • 依托单位:
海外基金